Intuitive Surgical, Inc. $ISRG Stock: Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Grows Holdings

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 235.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 138,050 shares of the medical equipment provider’s stock after acquiring an additional 96,938 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Intuitive Surgical were worth $56,135,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Aries Wealth Management increased its stake in shares of Intuitive Surgical by 5.6% during the 3rd quarter. Aries Wealth Management now owns 1,224 shares of the medical equipment provider’s stock worth $498,000 after purchasing an additional 65 shares during the last quarter. Tower View Wealth Management LLC raised its holdings in shares of Intuitive Surgical by 3.6% during the 3rd quarter. Tower View Wealth Management LLC now owns 5,919 shares of the medical equipment provider’s stock valued at $2,407,000 after purchasing an additional 206 shares in the last quarter. Hilton Head Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 35.2% in the 3rd quarter. Hilton Head Capital Partners LLC now owns 173 shares of the medical equipment provider’s stock valued at $70,000 after purchasing an additional 45 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its stake in shares of Intuitive Surgical by 15.5% in the 3rd quarter. Kingswood Wealth Advisors LLC now owns 3,720 shares of the medical equipment provider’s stock valued at $1,513,000 after purchasing an additional 498 shares during the last quarter. Finally, Sigma Planning Corp lifted its stake in shares of Intuitive Surgical by 0.7% in the 3rd quarter. Sigma Planning Corp now owns 7,998 shares of the medical equipment provider’s stock valued at $3,255,000 after purchasing an additional 58 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. Royal Bank Of Canada decreased their price objective on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a report on Wednesday, October 21st. Wells Fargo & Company reissued an “overweight” rating and set a $486.00 target price (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Wednesday, October 21st. BMO Capital Markets reaffirmed an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Finally, UBS Group reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Tuesday, October 13th. One analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $493.54.

Intuitive Surgical News Roundup

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Insider Buying and Selling at Intuitive Surgical

In related news, EVP Mark Brosius sold 77 shares of Intuitive Surgical stock in a transaction on Friday, August 21st. The shares were sold at an average price of $375.57, for a total value of $28,918.89. Following the transaction, the executive vice president owned 881 shares in the company, valued at $330,877.17. This trade represents a 8.04% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the business’s stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total transaction of $28,303.20. Following the transaction, the director directly owned 179 shares of the company’s stock, valued at approximately $70,364.90. This represents a 28.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,342 shares of company stock worth $4,882,357 in the last quarter. 0.60% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $452.29 on Monday. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88. The business’s 50 day moving average is $395.50 and its two-hundred day moving average is $408.83. The company has a market cap of $156.78 billion, a PE ratio of 54.69, a price-to-earnings-growth ratio of 3.12 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter last year, the firm posted $2.40 earnings per share. The company’s quarterly revenue was up 21.7% compared to the same quarter last year. As a group, equities analysts expect that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.